{
    "prompt": "\n    If no matching FDA-approved drugs are found, please return message with the following JSON schema:\n    {\n        \"Status\": \"no_match\",\n        \"Message\": \"No drugs are FDA-approved for the provided context\"\n    }\n    \n    If FDA-approved drugs are found, please provide each treatment as a json format with the following JSON schema:\n    {\n        \"Status\": \"success\",\n        \"Treatment 1\": {\n            \"Disease Name\": ,\n            \"Disease Phase or Condition\": ,\n            \"Drug Name\": ,\n            \"Prior Treatment or Resistance Status\": ,\n            \"Genomic Features\": \n            \"FDA-approval status\":\n            \"Link to FDA-approved Label\":\n            }\n    }\n    Query: \n    The following is a summarized molecular profile from MSK-IMPACT.\n    Based on this profile, answer with the appropriate treatments for this patient in the format above.\n    Patient ID: P-0012268\nAge: 57\nGender: Male\nSample ID: P-0012268-T01-IM5\nGene Panel: IMPACT410\nCancer Type: Colon Adenocarcinoma\nSample Type: Metastasis\nTumor Purity: 20.0%\n=============\nDNA Variants:\nAPC c.2861T>A (p.L954*) - in 24.00% of 1005 reads\nAPC c.3916delinsAA (p.E1306Kfs*9) - in 9.00% of 485 reads\nATM c.1009C>T (p.R337C) - in 13.00% of 788 reads\nEP300 c.2470C>T (p.Q824*) - in 16.00% of 1376 reads\nGRIN2A c.2371C>A (p.L791M) - in 15.00% of 712 reads\nKRAS c.34G>T (p.G12C) - in 13.00% of 750 reads\nPIK3CA c.263G>A (p.R88Q) - in 14.00% of 1705 reads\nPTEN c.43A>G (p.R15G) - in 19.00% of 314 reads\nRICTOR c.1018C>T (p.P340S) - in 11.00% of 1063 reads\nCNA Data:\nNo CNA data found.\nStructural Variants:\nNo structural variant data found.\n    ",
    "response": "{\n  \"Status\": \"no_match\",\n  \"Message\": \"No drugs are FDA-approved for the provided context\"\n}"
}